MH004 1.0% Ointment

DRUG2 trials

Sponsors

Minghui Pharmaceutical (Hangzhou) Ltd

Conditions

Atopic Dermatitis (AD)Vitiligo

Phase 1

MH004 Ointment in Healthy Adult Volunteers and Participants With Mild to Moderate Atopic Dermatitis

CompletedNCT07182864

Minghui Pharmaceutical (Hangzhou) LtdAtopic Dermatitis (AD)

Start: 2022-01-06End: 2022-10-08Updated: 2025-09-19

Phase 3

A Phase III Clinical Study to Evaluate the Efficacy and Safety of MH004 Ointment in Non-segmental Vitiligo

Not yet recruitingNCT07682506

Minghui Pharmaceutical (Hangzhou) LtdVitiligo

Start: 2026-07-15End: 2028-10-04Target: 405Updated: 2026-07-06